Grogan 2016 ATTRwt staging: 1 point when NT-proBNP >3000 ng/L; 1 point when cardiac TnT >0.05 ng/mL. Stage I = 0, II = 1, III = 2. Equal to a cutoff does not score. Cohort 4-year OS I 57% / II 42% / III 18%; stage III median 20 months (labels, not a prediction). Troponin T only. Not Gillmore NAC (no eGFR). Not Mayo AL. Not NYHA. magent does not assay the biomarkers.
| Network | Scheme | Amount | Pay To |
|---|---|---|---|
| Base | exact | $0.005000 USDC | 0x836B...9Ee2 |